Securities code: Allmed Medical Products Co.Ltd(002950) securities abbreviation: Allmed Medical Products Co.Ltd(002950) Announcement No.: 2022003 Allmed Medical Products Co.Ltd(002950)
Suggestive announcement on the listing and circulation of issued shares before the company’s initial public offering
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete without false records and errors
Leading statements or material omissions.
Special tips:
1. Allmed Medical Products Co.Ltd(002950) (hereinafter referred to as ” Allmed Medical Products Co.Ltd(002950) ” or “the company”) the shares to be released this time are part of the shares issued before the initial public offering of the company.
2. The number of restricted shares lifted this time is 240542806, accounting for 379845% of the total share capital of the company.
3. The listing and circulation time of the restricted shares is Friday, March 11, 2022.
1、 Basic information of the lifting of restricted shares this time
(I) initial public offering of shares
With the consent of the reply on approving Allmed Medical Products Co.Ltd(002950) initial public offering (zjxk [2019] No. 214) of China Securities Regulatory Commission and the notice on the listing of Allmed Medical Products Co.Ltd(002950) RMB common shares (SZS [2019] No. 99) of Shenzhen Stock Exchange, Allmed Medical Products Co.Ltd(002950) initial public offering of 48 million RMB ordinary shares was listed on Shenzhen Stock Exchange on March 11, 2019. After the initial public offering of shares, the total share capital of the company is 422176938 shares, including 48000000 tradable shares with unlimited conditions and 374176938 tradable shares with limited conditions.
(II) changes in share capital of the company
On May 20, 2020, the company held the 2019 annual general meeting of shareholders, deliberated and approved the proposal on 2019 profit distribution and capital reserve conversion to share capital, and distributed cash dividends of RMB 6.00 (including tax) for every 10 shares to all shareholders based on the total share capital of 42217693800 shares, with a total of RMB 25330616280 (including tax), The remaining undistributed profits shall be carried forward for subsequent annual distribution, and the capital reserve shall be converted into share capital, with 5 shares added for every 10 shares. The above equity distribution plan has been implemented on June 5, 2020. After increasing the share capital, the total share capital of the company has been changed from 422176938 shares to 633265407 shares.
2、 Commitments and performance of shareholders applying for lifting share restrictions this time
There are 7 shareholders applying for lifting the restrictions on the sale of shares, including 3 legal shareholders: Zhijiang Jinmei investment management service department (limited partnership) (hereinafter referred to as “Zhijiang Jinmei”), Qianjiang Puxiang enterprise management center (limited partnership) (formerly known as Ezhou Changjiang Puhui medical equity investment management center (Limited partnership), hereinafter referred to as “Qianjiang Puxiang”) Zhijiang Zhimei investment management service department (limited partnership) (hereinafter referred to as “Zhijiang Zhimei”). There are 4 natural person shareholders: Cui Jinhai, Wan Xiaoxiang, Cui Hui and Cui Xingwei.
(I) commitments made by the above shareholders in the company’s listing announcement on share locking and shareholding intention
Commitment type of commitment party commitment content commitment period performance
1. Within 36 months from the listing and trading date of Allmed Medical Products Co.Ltd(002950) shares in the stock exchange, this
The owner does not transfer or entrust others to manage the Allmed Medical Products Co.Ltd(002950) directly or indirectly held by him
The shares held before this public offering will not be repurchased by Allmed Medical Products Co.Ltd(002950)
Sub shares. For the public development directly or indirectly held by me based on Allmed Medical Products Co.Ltd(002950) this
Bonus shares, converted share capital and other shares enjoyed by the shares held before the issuance of shares shall also
Abide by the above agreement on lock period.
2. If the shares are reduced within 2 years after the expiration of the above lock-in period, the reduction price of such shares shall not be changed
Lower than the issue price of the initial public offering Allmed Medical Products Co.Ltd(002950) within 6 months after listing
The closing price of Allmed Medical Products Co.Ltd(002950) shares is lower than the issue price for 20 consecutive trading days, or
At the end of six months after listing, the closing price is lower than the issue price, and I directly or indirectly hold Austrian shares
The lock-in period of American Medical shares is automatically extended by 6 months.
Company control 3 After the expiration of the above lock-in period, I serve as a director, supervisor or supervisor in Allmed Medical Products Co.Ltd(002950) office
During the period of senior managers, the shares transferred each year shall not exceed the shares of Ogilvy medical held by me
25% of the total number of shares of Dongshi therapy; Purchase Allmed Medical Products Co.Ltd(002950) shares within six months after the sale
If the IPO shares of international control are locked up, or the Allmed Medical Products Co.Ltd(002950) shares are sold within six months after the purchase, the income will be in March 2019
Cui Jinding and restricted sales commitment belong to Allmed Medical Products Co.Ltd(002950) all; Within six months after my resignation, I will not transfer Allmed Medical Products Co.Ltd(002950) shares held by Hai and wannuo, which I am directly or indirectly performing from the 11th to the 11th. March 2022 within 12 months after I declare to leave office for six months
Xiao Xiang, the number of shares of the company sold through listing and trading on the stock exchange accounted for 11% of the total shares held by me
Cui Hui, the proportion of the total number of U.S. medical stocks does not exceed 50%. If I leave before the expiration of my term of office
Cui Xingwei is still committed to the term of office determined at the time of taking office and within six months after the expiration of his term of office
Continue to comply with the above provisions.
4. After the expiration of the above lock-in period, before the initial public offering of the company held by me
If the shares are reduced by means of centralized bidding transaction, they shall be held for 90 consecutive months at any time
Within a natural day, the total number of shares reduced shall not exceed 1% of the number of shares of the company;
If the shares are reduced by block trading, the shares shall be reduced within 90 consecutive natural days
The total number of shares shall not exceed 2% of the total number of shares of the company; I take measures to reduce my Holdings
In case of transfer by agreement, the transferor and the transferee shall continue to abide by the agreement within six months
Reduction of shareholders, directors, supervisors and senior managers of Listed Companies in Shenzhen Stock Exchange
The provisions of paragraph 1 of Article 4 of the detailed rules for the implementation of shares on the proportion of share reduction shall continue to be observed
Abide by the provisions of Article 13 and Article 14 on information disclosure.
5. I promise not to reduce my shares under any of the following circumstances: ① the company or
I am suspected of securities and futures violations and crimes, and I am being filed for investigation by the China Securities Regulatory Commission or arrested
During the period when the judicial organ files a case for investigation, as well as when the administrative punishment decision and criminal judgment are made
Less than six months after that; ② I have been certified for violating the business rules of the stock exchange
The stock exchange publicly denounced those who have not reached three months.
6. If the company is under any of the following circumstances, it shall be from the date when the relevant decision is made to the date when the company
Before the termination or resumption of the listing of shares, I promise not to reduce my shares: ① the company
Administrative penalties imposed by the CSRC due to fraudulent issuance or illegal disclosure of major information;
② The company disclosed or did not disclose important information due to suspected fraud in issuance or suspected violation of regulations
The crime was transferred to the public security organ according to law.
7. During the period, if the company has ex right and ex interest matters such as dividend distribution, share distribution and conversion of share capital,
The above prices shall be adjusted accordingly. The reduction methods include the centralized bidding trading system of the stock exchange
Unified or block trading system. I will timely and fully fulfill the of share reduction
The obligation of information disclosure, as the controlling shareholder, actual controller and holding shares of the company
If the reduction of shareholders’ holdings exceeds 5 days before the issuance of the transaction period
Suggestive announcement; As the controlling shareholder, actual controller and shareholder of the company
More than 5% of shareholders or directors, supervisors and senior managers, such as
If the shares are reduced through centralized bidding trading, it will be released 15 trading days before the first sale
Suggestive announcement of reduction.
8. I will abide by the regulations of the China Securities Regulatory Commission on the reduction of shares held by shareholders, directors, supervisors and senior executives of listed companies
Several provisions of Shenzhen Stock Exchange, Shenzhen Stock Exchange, stock listing rules, Shenzhen Securities
Actual reduction of shares held by shareholders, directors, supervisors and senior managers of listed companies on the exchange
Relevant provisions of the implementation rules.
Indirect holding 1 Within 36 months from the listing and trading date of Allmed Medical Products Co.Ltd(002950) shares in the stock exchange, this
There is a company that does not transfer or entrust others to manage Allmed Medical Products Co.Ltd(002950) directly or indirectly held by itself
Allmed Medical Products Co.Ltd(002950) will not buy back the shares held before this public offering
The company holds shares. For the public development directly or indirectly held by me based on Allmed Medical Products Co.Ltd(002950) this
Bonus shares, converted share capital and other shares enjoyed by the stock bank for the shares held before the shares are also
Dongshi IPO share lock shall comply with the above agreement on lock period. March 2019
International control formulation and sales restriction commitment 2 Within 6 months after Allmed Medical Products Co.Ltd(002950) listing, if the closing price of Allmed Medical Products Co.Ltd(002950) shares from the 11th day of 20 consecutive trading days to the recent promise of the performing party is lower than the issuing price, or the closing price at the end of 6 months after listing is lower than the issuing price in March 2022
The lock up period of Allmed Medical Products Co.Ltd(002950) shares held directly or indirectly by my relative Cui Xingjia will be automatically extended for 11 days
Caizhi, 6 months.
Cui Cai 3 During the period, if the company has ex right and ex interest matters such as dividend distribution, share distribution and conversion of share capital,
The above prices of Yun and Li are adjusted accordingly. The reduction methods include the centralized bidding trading system of the stock exchange
Jinping, unified or block trading system.
Bai Dehou
1. Within 12 months from the date when Allmed Medical Products Co.Ltd(002950) shares are listed on the stock exchange,
The enterprise does not transfer or entrust others to manage the assets directly or indirectly held by the enterprise
The shares held by the company’s stock Meimei medical before this public offering will not be returned by Allmed Medical Products Co.Ltd(002950) either
Dongjinmei’s IPO shares lock up this part of the shares. For the direct or indirect held by the enterprise based on Allmed Medical Products Co.Ltd(002950) this March 2019
From the 11th to the end of the performance of Bi Zhimei’s investment promise shares, such as bonus shares and share capital conversion enjoyed by investing, fixing and restricting the sale of shares held before the sub public offering of shares, also abide by the above-mentioned lock-in period. March 2020
2. Capital and potential After the expiration of the above lock-in period, the initial public offering of the company held by the enterprise shall be held for 11 days
If Jiang Puxiang’s former shares are reduced by means of centralized bidding trading, they will be sold for 90 consecutive days at any time
Within a natural day, the total number of shares reduced shall not exceed percent of the number of shares of the company
1; If the reduction is carried out by block trading, within 90 consecutive natural days,
The total number of shares reduced shall not exceed 2% of the total number of shares of the company; Less for the enterprise
If the transfer agreement is adopted, the transferor and transferee shall continue to transfer within six months
Comply with the regulations on shareholders, directors, supervisors and senior management of Listed Companies in Shenzhen Stock Exchange
The provisions on the proportion of share reduction in paragraph 1 of Article 4 of the detailed rules for the implementation of share reduction by personnel shall also
Continue to comply with the provisions of Article 13 and Article 14 on information disclosure.
3. The company will abide by the “shareholding reduction of shareholders, directors and supervisors of listed companies” issued by China Securities Regulatory Commission
Several provisions of Shenzhen Stock Exchange, the stock listing rules of Shenzhen Stock Exchange
Reduction of shareholders, directors, supervisors and senior managers of Listed Companies in Shenzhen Stock Exchange
Relevant provisions of the detailed rules for the implementation of shares
